Piper Sandler lowered the firm’s price target on Dyne Therapeutics (DYN) to $48 from $53 following ATM dilution, while keeping an Overweight ...
Andy Laperriere, Piper Sandler head of U.S. policy, joins 'The Exchange' to discuss the questions around the budget ...
Couchbase (NASDAQ:BASE – Get Free Report) had its target price upped by research analysts at Piper Sandler from $21.00 to $22 ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Celanese (NYSE:CE – Free Report) had its price target lowered by Piper Sandler from $77.00 to $50.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has an underweight ...
The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...
LONDON & NEW YORK, February 19, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ahsan Khan as a managing director along with Jonathan ...
Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm with a market capitalization of $5.1 billion, has demonstrated robust performance and strategic ...
Piper Sandler reported Q4 2024 adjusted net revenues of $499 million, exceeding analysts' revenue estimates of $454.36 million. Adjusted EPS of $4.80 also surpassed the analysts' EPS estimate of ...
Fintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a ...